Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-11-09 00:00:00 ET · period of report 2023-11-09 · accession 0001209191-23-054846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-11-09 | 2023-11-09 | PCVX | Paya Carlos V | Dir | A - Grant | $0.00 | +3,125 | 3,125 | New | $0 |
| D | 2023-11-09 | 2023-11-09 | PCVX | Paya Carlos V | Dir | G - Gift | $0.00 | -3,125 | 2,500 | -56% | $0 |
| DMI | 2023-11-09 | 2023-11-09 | PCVX | Paya Carlos V | Dir | G - Gift | $0.00 | +63.8K | 15.0K | New | $0 |
| DM | 2023-11-09 | 2023-11-09 | PCVX | Paya Carlos V | Dir | G - Gift | $0.00 | -63.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-09 | A | A | 3,125 | $0.00 | 3,125 | I | — | — | (F1) The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. |
| 2 | Common | Common Stock | 2023-11-09 | G | D | 3,125 | $0.00 | 2,500 | D By Family Trust | — | — | (F1) The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. (F2) As previously disclosed in Reporting Person's Form 4 filed on June 15, 2023, this represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. (F3) Shares are held directly by a trust for the sole benefit of the Reporting Person. |
| 3 | Derivative | Stock Option (right to buy) | 2023-11-09 | G | A | 30,000 | $0.00 | 30,000 | I By Family Trust | $22.02 · — to 2031-10-26 | 30,000 Common Stock | (F1) The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. (F5) Options are held directly by a trust for the sole benefit of the Reporting Person. (F4) Option vests over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |
| 4 | Derivative | Stock Option (right to buy) | 2023-11-09 | G | D | 18,750 | $0.00 | 0 | D By Family Trust | $22.70 · — to 2032-05-31 | 18,750 Common Stock | (F1) The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. (F5) Options are held directly by a trust for the sole benefit of the Reporting Person. (F6) The shares of Common Stock subject to the option vested fully on June 1, 2023. |
| 5 | Derivative | Stock Option (right to buy) | 2023-11-09 | G | A | 18,750 | $0.00 | 18,750 | I | $22.70 · — to 2032-05-31 | 18,750 Common Stock | (F1) The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. (F6) The shares of Common Stock subject to the option vested fully on June 1, 2023. |
| 6 | Derivative | Stock Option (right to buy) | 2023-11-09 | G | D | 15,000 | $0.00 | 0 | D | $53.08 · — to 2033-06-12 | 15,000 Common Stock | (F1) The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. (F7) The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. |
| 7 | Derivative | Stock Option (right to buy) | 2023-11-09 | G | A | 15,000 | $0.00 | 15,000 | I | $53.08 · — to 2033-06-12 | 15,000 Common Stock | (F1) The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. (F7) The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. |
| 8 | Derivative | Stock Option (right to buy) | 2023-11-09 | G | D | 30,000 | $0.00 | 0 | D By Family Trust | $22.02 · — to 2031-10-26 | 30,000 Common Stock | (F1) The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person. (F5) Options are held directly by a trust for the sole benefit of the Reporting Person. (F4) Option vests over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |